Mostrar el registro sencillo del ítem
Disease recurrence during supportive therapy following peri-implantitis treatment: a retrospective study
dc.contributor.author | Monje, Alberto | |
dc.contributor.author | Nart Molina, José | |
dc.date.accessioned | 2024-05-24T09:13:38Z | |
dc.date.available | 2024-05-24T09:13:38Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Monje, Alberto; Nart Molina, José. Disease recurrence during supportive therapy following peri-implantitis treatment: a retrospective study. Journal of Periodontal Research, 2024, p. 1-11. Disponible en: <https://onlinelibrary.wiley.com/doi/10.1111/jre.13281>. Fecha de acceso: 24 may. 2024. DOI: 10.1111/jre.13281 | ca |
dc.identifier.issn | 0022-3484 | ca |
dc.identifier.uri | http://hdl.handle.net/20.500.12328/4252 | |
dc.description.abstract | Aim: Supportive therapy is key to prevent disease recurrence after peri-implantitis treatment. The primary objective was to quantify disease recurrence during supportive peri-implant therapy (SPIT) after peri-implantitis treatment. A secondary objective was to assess the success/failure of cumulative interceptive supportive therapy (CIST) after peri-implantitis treatment. Methods: Compliers (whether regular or erratic) with SPIT after peri-implantitis treatment during ≥12 months were retrospectively evaluated. CIST was prescribed whenever residual pockets ≥6 mm concomitant with profuse bleeding on probing (disease recurrence) were identified. Patient- and implant-related factors were analyzed to explore their associations with disease recurrence and the need for CIST. Results: Disease recurrence was considered in 28 patients (40 implants). Of these, 14 patients (23 implants) further demonstrated radiographic evidence of progressive bone loss (≥1 mm). This represented an overall disease recurrence following peri-implantitis treatment of ~20% and ~ 10% at patient and implant levels, respectively. Smokers, patients diagnosed at baseline with periodontitis grade C, and males were significantly more prone to exhibit recurrence. Patients undergoing CIST due to instability were not likely to respond favorably (~70% continued to exhibit residual pockets). Conclusion: Disease recurrence during SPIT following peri-implantitis treatment on selected cases is ~20%. Patients undergoing CIST due to instability are not likely to respond favorably. | ca |
dc.format.extent | 11 | ca |
dc.language.iso | eng | ca |
dc.publisher | Wiley | ca |
dc.relation.ispartof | Journal of Periodontal Research | ca |
dc.rights | © 2024 The Authors. Journal of Periodontal Research published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,provided the original work is properly cited. | ca |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject.other | Implant dental | ca |
dc.subject.other | Manteniment dental | ca |
dc.subject.other | Periimplantitis | ca |
dc.subject.other | Malaltia periodontal | ca |
dc.subject.other | Teràpia de suport | ca |
dc.subject.other | Implante dental | ca |
dc.subject.other | Mantenimiento dental | ca |
dc.subject.other | Periimplantitis | ca |
dc.subject.other | Enfermedad periodontal | ca |
dc.subject.other | Terapia de apoyo | ca |
dc.subject.other | Dental implant | ca |
dc.subject.other | Dental maintenance | ca |
dc.subject.other | Peri-implantitis | ca |
dc.subject.other | Periodontal disease | ca |
dc.subject.other | Supportive therapy | ca |
dc.title | Disease recurrence during supportive therapy following peri-implantitis treatment: a retrospective study | ca |
dc.type | info:eu-repo/semantics/article | ca |
dc.description.version | info:eu-repo/semantics/publishedVersion | ca |
dc.rights.accessLevel | info:eu-repo/semantics/openAccess | |
dc.embargo.terms | cap | ca |
dc.subject.udc | 616.3 | ca |
dc.identifier.doi | https://dx.doi.org/10.1111/jre.13281 | ca |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Odontologia [239]